Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
117
天
Long‐term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy
作者
Oded Icht; Inbar Nardi‐Agmon; Paaladinesh Thavendiranathan; Shaf Keshavjee; Amiya Agrawal; John‐Michael Miro; Omar Badran; Geoffrey Liu; Xiang Y. Ye; B. C. John Cho; Andrea Bezjak; Andrew Hope展开收起
作者单位
1. Radiation Medicine Program Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada; 2. Department of Radiation Oncology University of Toronto Toronto Ontario Canada; 3. Gray Faculty of Medical and Health Sciences Tel‐Aviv University Tel‐Aviv Israel; 4. Department of Medicine Division of Cardiology Ted Rogers Program in Cardiotoxicity Prevention Peter Munk Cardiac Center Toronto General Hospital University Health Network University of Toronto Toronto Ontario Canada; 5. Division of Thoracic Surgery University of Toronto Toronto General Hospital and Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada; 6. Department of Medical Oncology Princess Margaret Cancer Centre Toronto Ontario Canada; 7. Department of Biostatistics Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada展开收起
41
天
GPRC5D‐targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies
作者
Darren Pan; Anupama Kumar; Jodi J. Lipof; Alfred Chung; Jeffrey L. Wolf; Thomas G. Martin; Shagun Arora; Peter H. Sayre; Ajai Chari展开收起
作者单位
1. Department of Medicine University of California San Francisco California USA展开收起
79
天
Adjuvant CDK4/6 inhibitors in early‐stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection
作者
Austin D. Williams; Anna Weiss展开收起
作者单位
1. Division of Breast Surgery Department of Surgery Fox Chase Cancer Center Philadelphia Pennsylvania USA; 2. Pluta Cancer Center University of Rochester Rochester New York USA展开收起
71
天
The past, present, and future treatment of BRAF V600 ‐mutant metastatic colorectal cancer: A comprehensive review
作者
Iris Dirven; Celina Ang; Cleo Bertels; Koen Kortbeek; Amy de Haar‐Holleman; Marieke Vollebergh; Poulikos Poulikakos; Bart Neyns展开收起
作者单位
1. Team Laboratory for Medical and Molecular Oncology Translational Oncology Research Center, Department of Medical Oncology, Vrije Universiteit Brussel and Universitair Ziekenhuis Brussel Brussels Belgium; 2. Division of Hematology/Oncology, Department of Medicine Tisch Cancer Institute, Mount Sinai Hospital New York New York USA; 3. Department of Medical Oncology Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital Amsterdam Netherlands; 4. Department of Gastrointestinal Oncology Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital Amsterdam Netherlands; 5. Department of Oncological Sciences The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York USA展开收起
109
天
Disease‐free survival as a surrogate outcome for localized kidney cancer—A systematic review and meta‐analysis
作者
Constanza Martinez; David Chen; Russell Leong; Nicholas Lum; Karren Xiao; Laith Almasri; Christian K. Kollmannsberger; Srinivas Raman展开收起
作者单位
1. Department of Radiation Oncology McGill University Health Center Montreal Quebec Canada; 2. Radiation Medicine Program Princess Margaret Hospital Cancer Center Toronto Ontario Canada; 3. Temerty Faculty of Medicine University of Toronto Toronto Ontario Canada; 4. Faculty of Medicine University of Ottawa Ottawa Ontario Canada; 5. Department of Medical Oncology British Columbia Cancer Vancouver Vancouver British Columbia Canada; 6. Department of Radiation Oncology British Columbia Cancer Vancouver Vancouver British Columbia Canada展开收起
89
天
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings—international expert consensus
作者
Daniel J. DeAngelo; Anna Avagyan; Jeanine Alfaro; Valentino Conter; Maria L. de Martino Lee; Łukasz Hutnik; Miriam Hwang; Hiroto Inaba; Atsushi Manabe; Jae H. Park; Rob Pieters; Carmelo Rizzari; Vaskar Saha; David T. Teachey; Inge M. van der Sluis; Scott C. Howard展开收起
作者单位
1. Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA; 2. Pediatric Cancer and Blood Disease Center Yeolan Hematology and Oncology Center Yerevan Armenia; 3. Department of Pediatrics Unidad Nacional de Oncología Pediatrica Guatemala City Guatemala; 4. Tettamanti Center IRCCS San Gerardo dei Tintori Monza Italy; 5. Beneficência Portuguesa de São Paulo Sao Paulo Brazil; 6. Pediatric Oncology, Hematology and Clinical Transplantology Medical University of Warsaw Warsaw Poland; 7. Resonance Memphis Tennessee USA; 8. Department of Oncology St Jude Children’s Research Hospital Memphis Tennessee USA; 9. Department of Pediatrics Hokkaido University Graduate School of Medicine Hokkaido Japan; 10. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA; 11. Princess Máxima Center for Pediatric Oncology Utrecht Netherlands; 12. Pediatric Hematology‐Oncology Unit IRCCS San Gerardo dei Tintori Monza Italy; 13. Division of Cancer Sciences University of Manchester School of Medicine Manchester UK; 14. Center for Childhood Cancer Research Children’s Hospital of Philadelphia Philadelphia Pennsylvania USA; 15. Yeolyan Hematology‐Oncology Center Yerevan Armenia展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天